The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
Amazon should acquire Rite Aid to obtain state pharmacy licenses and add a regulatory-cleared infrastructure, according to one Wall Street analyst on Tuesday.
Both Amazon and Rite Aid offered no comment for this story. Shares of Rite Aid were up more than 5 percent late morning Tuesday after the Cowen report.
The deal suggestion was part of a larger report by Blackledge on why Amazon should get into the business of selling prescription drugs. The e-commerce giant has been quietly exploring ways to expand into the health-care industry. CNBC reported in May that Amazon has been recruiting health insurance experts to develop an internal pharmacy benefits manager for Amazon employees.
"Our Cowen proprietary survey data suggests 67 percent of Amazon Prime members would purchase prescription drugs through Amazon if they were available," wrote Blackledge. "Depending on the pace Amazon would seek to enter the market, an acquisition such as Rite Aid could accelerate the pace and be a relatively low-risk acquisition given that it currently trades at an enterprise value of only about $5 billion."
If an Amazon-Rite Aid deal were to materialize, the analyst argues that Amazon's U.S. retail pharmacy business could generate about $20 billion in 2019 with 10 percent market share. Amazon would inherit pharmacy licenses in 19 states as well as adopt six distribution centers and 2,575 regulatory-cleared stores, a sizable leg up for the e-commerce giant.
Many Wall Street strategists view the recent CVS-Aetna merger talks as evidence that some of the industry's major players are also wary of Amazon's ambitions in the space. If Amazon entered the pharmacy benefit manager space, Amazon could serve as its own mail-order drug business.
"We think Amazon could enter the pharmacy benefit manager business (PBM)," added Blackledge. "A simple case one can make for Amazon to enter the PBM space is that it can serve as its own mail pharmacy, and capitalize on Prime 2-day delivery. From there, Amazon could build out its own retail network, and find itself working with other retail pharmacy chains to participate in its retail network."
Earlier this year drugstore chain Walgreens Boots Alliance ditched its deal to buy Rite Aid after struggling to win antitrust approval.
Instead, Walgreens received clearance from the Federal Trade Commission to buy 1,932 stores from Rite Aid for $4.38 billion.